The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential decision reversing a district court’s ...

Swiss pharma giant Novartis has expressed its satisfaction at a decision by the US Court of Appeals for the Federal Circuit ...

In a pivotal decision Friday, the Federal Circuit revived a key patent for Novartis' blockbuster heart failure drug Entresto, ...

The best Android tablets can do it all. They pack enough power to run apps and games with minimal or no slowdown. They're also energy-efficient enough to last long on a single charge. And when ...

In our Case of the Week, the Federal Circuit revived Novartis’s US Patent No. 8,101,659 by reversing the district court’s decision which found the patent invalid for lack of written description. The ...

Novartis (NYSE:NVS) said the U.S. Court of Appeals for the Federal Circuit has upheld the company's U.S. combination patent for its blockbuster cardiac drug Entresto, also known as ...

If you’re in the market for a tablet and are looking for the best options priced under Rs. 15,000, you’ve come to the right place. This is a list of tablets under Rs. 15,000 currently on sale in India ...

Large tablets often feel large and unwieldy, but some manufacturers have taken this into consideration by combining lightweight designs with premium materials and excellent viewing angles.

The Gadgets 360 Best Tablets page shows the top-rated tablets reviewed by us in the recent past. The tablets were launched less than 2 years ago, and have received a rating of 8 or above. When you ...

(RTTNews) - Swiss drug major Novartis (NVS) Monday announced that the US Court of Appeals for the Federal Circuit or CAFC has decided to upheld the validity of the Entresto (sacubitril/valsartan) ...

Tablets are used for a variety of reasons, but they're especially perfect for note taking. These devices are a digital alternative to pen and paper, making it easier than ever for students and ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...